Register for the Event

* fields required
First Name:*
Last Name:*
Mobile No: *
E- mail: *

Security Question*

Please enter your answer:


Register for the Event

* fields required
First Name:*
Last Name:*
Mobile No: *
E- mail: *

Security Question*

Please enter your answer:


Anomaly Certification - Sample Images



Rajpura Outreach Programme

Date: 5th August 2018 9.00 – 1.00 pm
Venue: Neelam Hospital, NH64, Opp. Chitkara University, Rajpura. Punjab


Dr Anita Kaul
HOD, Fetal Medicine, Apollo Center For Fetal Medicine, New Delhi
Dr Rachna Gupta
Consultant. Sonepat Fetal Medicine and Genetic Center,
Visiting Consultant, Apollo Center For Fetal Medicine



  • 09.15-09.30 am Welcome address – Dr Shikha Gupta
  • 09.30-10.00 am First Trimester Screening – current concepts – Dr Anita Kaul
  • 10.05-10.25 am Role of Biochemistry in Screening: Quadruple marker in the second trimester – Dr Gurika Aggarwal
  • 10:30-10.50 am Early vs Late Fetal Growth Restriction – Dr Rachna Gupta
  • 10:55-11:15 am Tea Break
  • 11:15-11.40 am Screening & prevention of pre-eclampsia – overview – Dr Anita Kaul
  • 11.45-01.00 pm Live DEMO case Based with audience interaction – Dr Anita Kaul & Dr Rachna Gupta
  • 1:00 pm – Lunch

International Hands-on Course on Fetal Neurosonography: From Theory to Practice

Date: 22 and 23 Sep 2018
Venue: Auditorium, Indraprastha Apollo Hospital, Sarita Vihar, New Delhi

Dr. Karina Krajden Haratz
Tel Aviv Medical Center / Wolfson Medical Center
karinaSpecialist in Fetal Medicine and Fetal Neuroimaging, Senior Consultant at the Fetal Neurology Clinic (Wolfson Medical Center) and at the ObGyn US Unit at Tel Aviv Medical Center, Israel. Researcher and Lecturer affiliated to the Tel Aviv University. Faculty Member of the Fetal Neurology Masterclass Israel.

Target audience
Sonologists and Fetal Medicine practitioners, ObGyn Ultrasound consultants (max 20 delegates for hands-on)

A unique 2-day intensive learning experience on Fetal Neurosonography focused on the exam technique and definition of normal imaging patterns: Hands-on training, dedicated time with expert, state-of-the art lectures, 3D practice with real-case volumes.

Programme schedule
Day 1
8:00 Registration and opening
8:30 Physical aspects and presets for better imaging the fetal CNS
09:15 Technical aspects of the Neurosonographic exam
10:00 Neurosonoembryology
10:45 Coffee break
11:15 The lateral ventricles: developmental sonoanatomy and work-up in ventriculomegaly
12:15 Developmental sonoanatomy of the anterior complex and the CC and abnormal imaging patterns
13:45 Lunch
14:45 Live scan 1
15:15 Group hands-on training
Day 2
8:00 Developmental sonoanatomy of midbrain-hindbrain structures and the differential diagnosis of MB-HB anomalies
09:30 3D neurosonography – tips and tricks
10:15 Coffee break
10:45 The fetal brain parenchyma and cortex – normal development and patterns of disease
12:00 The brain vasculature and congenital vascular malformations.
13:00 Lunch
14:00 Live scan 2
15:00 Alternate groups – hands on / 3D practice

Registration Fees : 32000 for theory with hands-on practical
17000 for only theory 

Registration closed for Hands On Practical. You can still register for theory course.

*Delegates appearing for practical session need to submit documents of their degree, med council reg and affidavit.


1. Bank Transfer to A/c No: 03192560004661; HDFC Bank, South Extension Branch, New Delhi; IFSC Code: HDFC0000319
2. Post Cheque in favour of “Fetal Medicine Foundation,India” to:
Apollo Centre for Fetal Medicine,
Gate No:7, Indraprastha Apollo Hospitals , Sarita Vihar, New Delhi,110044

For Queries Contact: Dr Rachna Gupta, General Secretary: 09899294499 Dr Akshatha Sharma, Programme Coordinator : 09891494545 or write to



Download PDF

Download Affidavit

FMF UK Anomaly Certification: Practical Examination Schedule

Practical Examination Date: 7th April 2018
09:30-10:00 Alpesh Kumar Pancholi Anitha Joseph Anita Kulshreshtha
10:05-10:35 Asha Ravindran Shikha Mehta Chander Mohini
10:40-11:10 Debabrata Maitra Dr Navya N Dr Swati Kshirsagar
11:15-11:30 TEA BREAK
11:35-12:05 Karuna Yadav Jarita Deb Neelam Chhajed
12:10-12:40 Bhavna Anand Sabila A Rinshi Elayedatt
12:45-01:15 Sreeja Ps Sripriya Thiruvengadathan Harpreet Kehal
1:20-2:00 LUNCH BREAK
2:05-2:35 Sumona Haque Asegaonkar Prashant Tukaram Sumati Saxena
2:40-3:10 Vijay Patil Nalluri Hima Bindu Arati Appinabhavi
3:15-3:45 Neena Prajakta Aloorkar Samriti Sharma
3:50-4:20 Shweta Nagar Sirisha Hari Shreshtha
  • The above candidates are eligible provided they bring the proof (hard copy) of their FMF UK approval of images and subject to payment of the fees as mentioned in the brochure.
  • Each candidate is expected to assemble at Gate no 7, Apollo  Centre for Fetal Medicine atleast 45 mins prior to their scheduled time of the exam.
  • Each candidate will be allotted 30 mins per patient to show the standard FMF views to the examiner. An MCQ test will be conducted post the practical exam.
  • Kindly note that candidates will have to arrange for their own lunch on the day of the practical exams (Options available at Apollo Food Court).

A Case of Split Cord Malformation

Mrs X, 29 years of age

  • Primigravida with 18+6weeks period of gestation
  • First trimester combined screening low risk for aneuploidies
  • Referred to ACFM with diastometomelia in an anomaly scan done elsewhere.


Diastematomyelia (also termed diplomyelia, pseudodiplomyelia, dimyelia, and split spinal cord malformation syndrome) is a rare developmental deformity in which the spinal cord is separated into two parts by a rigid or fibrous septum. The incidence of diastometomelia is unknown and deformity is often accompanied by abnormal development of the vertebrae.1

One such case was a Primi 18+6 Mrs X who was referred to Apollo Centre for Fetal Fedicine, New Delhi. The anomaly scan at ACFM confirmed the diagnosis of Split cord malformation. Divarication of the fetal spine was seen at the thoracolumbar level(below T 12). Figure 1b. There did not appear to be any mass lesion and the overlying skin was intact. However, the spinal cord appeared tethered, the conus medularis ending at L5 S1 level. Figure 1c. Both the lower limbs were seen to be moving well.

Fetal brain appeared normal. Fetal growth and amniotic fluid was normal. There was no other structural defects nor any markers for chromosomal abnormalities. The couple was explained that cutaneous stigmata(like hairy patch, capillary hemangioma could be seen in 30% of the neonates and is not identifiable on ultrasonography antenatally. They were explained that diastometomelia is a treatable condition but the baby may require postnatal neurosurgery after birth.

MRI done at Apollo Hospital confirmed the diagnosis of Diastometomelia, figure 2. The couple had a detailed discussion with the neurosurgeon who explained them the prognosis of the baby and the good outcomes of the neurosurgery if at all it will be required. She was send back to her referral obstetrician

The couple decided to continue with the pregnancy and had a follow up with us at 32 weeks. The fetal growth and Dopplers were normal. Good fetal movements were perceived by the mother and were seen on the scan as well.

The woman had an emergency caesarean section at her local hospital at 38 weeks in view of preterm rupture of membranes followed by non reassuring fetal heart rate pattern. The baby weight was 2kg with an APGAR score of 9,9. Post natal MRI showed cord tethering and the baby was planned for surgery at 6 month. However, a repeat MRI at 4 months showed the diagnosis of Diatometomelia type 2(milder form) and the baby was decided to be kept on conservative management. The baby at 6 months of age is doing well.

Diastematomyelia is a rare congenital anomaly that results in a longitudinal split of the spinal cord. There are two types of disease entity knwon. Type 1 and Type 2.

In type I, the two hemicords are typically separated by a fibrous, cartilaginous, or osseous septum and reside in two separate dural tubes (Figure 7). Whereas, in Type II split cord malformations both the hemicords lie withina single, non-duplicated, dural tube[2].

The two hemicords typically reunitecaudally, though two coni medullarae may be seenin diplomyelia, an embryologically distinct entity[3].Diastematomyelia is typically associated with vertebralsegmental anomalies.

The majority of patients with diastematomyelia when they grow up are symptomatic, presenting with signs and symptoms of tethered cord, although patients with mild type II may be minimally affected or entirely asymptomatic. Presenting symptoms include: leg weakness, low back pain , scoliosis, incontinence making an individual dependent for life. Another indication of this syndrome is abnormal skin in the lumbosacral region, which may be a hairy patch (hypertrichosis), a pigmented area in the midline, or a dermal sinus[4]

Prenatal Diagnosis: Diastometomelia may go unnoticed by an unexperiened but the presence of an echogenic structure extending from the posterior elements to the posterior aspect of a vertebral body, has high specificity for diastematomyelia[5, 6,].

One third of the patients have an associated spinal dysraphism. The disease has a better prognosis when isolated. So care should be taken to rule out other neural tube defects. Prenatal MRI can be used to confirm the diagnosis of diastometomelia and to rule out other structural defects in the fetus.

Prognosis: The overall prognosis of diastometomelia is good and when indicated, surgical intervention includes decompression of the neural elements with excision of the interposing tissue and reconstruction of the duplicated
dural sacs.

1.Liu W, Zheng D, et al. Characteristics of osseous septum of split cord malformation in patients presenting with scoliosis: a retrospective study of 48 cases. Pediatr Neurosurg 2009; 45: 350–353
2.Pang D, Dias MS, Ahab-Barmada M. Split cord malformation: Part I: A unified theory of embryogenesis for double spinal cord malformations Neurosurgery 1992; 31: 451-480.
3.Cheng B, Li FT, Lin L. Diastematomyelia: a retrospective review of 138 patients. J Bone Joint Surg Br 2012; 94: 365-372.
4.Cheng B, Wang SK, Sun ZC, et al. Analysis of 46 cases of diastematomyelia. Chin J Orthop1996; 16: 97–100.
5.Blondiaux E, Katorza E, Rosenblatt J, Nahama-Allouche C, Lenoir M, le Pointe HD, Garel C. Prenatal US evaluation of the spinal cord using high frequency linear transducers. Pediatr Radiol 2011; 41: 374-383.
6.Glenn OA, Barkovich J. Magnetic resonance imaging of the fetal brain and spine: an increasingly important tool in prenatal diagnosis: part 2. AJNR Am J Neuroradiol 2006; 27: 1807-1814.

Aanchal Sablok MS(ObGyn), Fellow Fetal Medicine (ACFM)

FMF – UK Anomaly Certification – Theory Course and Practical Exam

Date: 7th and 8th April 2018
Venue: Auditorium, Indraprastha Apollo Hospitals, New Delhi

Note: Registration for Practical exam on 7th April is now closed. Please register if you are interested in the Theory course only.

The Anomaly scan is considered as the most important scan in pregnancy and it is medico-legally important to perform it to the best of standards, with proper documentation of images. Enhance your skills at detecting birth defects to the standards required by the Fetal Medicine Foundation UK and the International Society of Ultrasound in Obstetrics and Gynaecology (ISUOG).
The course is useful for all those who are involved in obstetric scanning.
All Faculty are accredited by FMF-UK

The FMF-UK certified course for 18-23 weeks Anomaly will satisfy the theory requirements for the Certificationand for those who are eligible for the practical exam(ie those whose images have been approved by FMF-UK )will have a chance to appear for the Practical Assessment.

The requirements for obtaining the FMF certificate of competence in the 18-23 weeks scan are:
  • Attendance of FMF Approved Theory course (8th April 2018 or previously attended approved course )
  • Online submission of a log-book of a series of images from one normal fetus to FMF-UK (it takes approximately 2 weeks for approval of images post submission to
  • Demonstration to a FMF approved examiner of competence in carrying out a 18-23 weeks scan and good knowledge of the diagnosis and management of a wide spectrum of fetal abnormalities
Please Note : The practical examination(max 30 candidates for practicals on 7th April) will be held for those who have already submitted the log book of images to FMF – UK and images have been approved(please contact us or visit or Click Here for details on submission of images). The theory course will be held on 8th April,2018.

Requirements for Practical Examination:

I. Registration with PNDT appropriate authority (South East District, Saket, Delhi) at least 30 days in advance of the date of practical examination (7th April 2018).

Documents required for PNDT registration, to be submitted at Apollo Centre for Fetal Medicine, Indraprastha Apollo Hospital, New Delhi for getting registration for the hands-on

  • Affidavit on INR 10 stamp paper attested by notary.
    The affidavit format is available for download below
  • Copy of qualification certificates (MBBS/MD/MS) self attested.
  • Copy of DMC / MCI registration (self attested).
Theory Programme
08:15-08:40 Registration
08:45-08:55 Welcome and Introduction Dr Anita Kaul
09:00-09:45 Central Nervous System: Normal & Abnormal Views Dr Akshatha Sharma
09:50-10:10 Face: Normal and Abnormal Views Dr Rachna Gupta
10:15-10:25 TEA BREAK
10:30-11:15 Heart : Normal Views Dr Deepak Bansal
11:20-12:05 Heart : Abnormal Views Dr Deepak Bansal
12:10-12:55 Pulmonary System Dr Anita Kaul
01:00-01:45 LUNCH BREAK
01:50-02:30 Gastrointestinal Tract and Abdominal Wall: Normal and Abnormal Views Dr Deepak Bansal
02:35-02:55 Kidneys and Urinary Tract: Normal and Abnormal Views Dr Akshatha Sharma
03:00-03:45 Skeletal System: Normal and Abnormal Views Dr Rachna Gupta
03:50-04:20 Second Trimester Soft Markers and Risk Calculation Dr Anita Kaul

Registration Fees : INR 5000/- 


1. Bank Transfer to A/c No: 03192560004661; HDFC Bank, South Extension Branch, New Delhi; IFSC Code: HDFC0000319
2. Post Cheque in favour of “Fetal Medicine Foundation,India” to:
Apollo Centre for Fetal Medicine,
Gate No:7, Indraprastha Apollo Hospitals , Sarita Vihar, NewDelhi,110044


For Queries call Himanshi on 9560127575, 011-29873018, 26925858; Extn 3018, or write to

Dr Rachna Gupta, General Secretary: 09899294499
Dr Akshatha Sharma, Programme Coordinator : 09891494545

Anomaly Practical Exam Candidate Schedule


Download PDF

Download Affidavit


Ques 1. Who all are eligible for theory?
All those who are involved in obstetric scanning.

Ques 2. Who are eligible to appear for practical examination on 7th April 2018?
Doctors whose images have been approved by FMF-UK before 21th March, 2018 and providedthe requisite documents and affidavitfor PCPNDT registration are sent beforehand to Apollo Centre for Fetal Medicine by 7th March 2018.

Ques 3. Is it a must to get registered with Delhi Medical Council?
No, any state medical council or MCI registration will suffice.

Ques 4. What if my images are not approved before practical examination?
You can appear for theory on 8th April 2018. If your images are approved by 31st July 2018 by FMF-UK, you can appear for practical examination in Sep
2018, there will be no separate registration fee for same.

Ques 5. Will there be repeat theory course in year 2018?
Ques 6. Will there be repeat theory course/ practical in the year 2019 or later?
Yes, but registration fee will be separate.

Ques 7. Will I get FMF UK Certification for Anomaly if I attend only the Theory Course?
No. FMF UK Certification for anomaly can be obtained only after you have:
1). Received approval from FMF UK for the logbook of images submitted,
2). Cleared your practical exam and
3). Attended the FMF approved Theory Course

However, you shall receive a certificate of attendance for the Theory course.

Ques 8. When can we know about our eligibility for the practical exam after submitting the documents?
All those finalized for the practical exam (subject to PCPNDT approval) will be informed about their schedule for the practical exam by 21th March,2018.

World Prematurity Day


Magnitude of problem

Around the world, 15 million babies are born prematurely (Less than 37 completed weeks) every year and one million of these will not survive due to complications of preterm birth.
Worldwide 1 in 10 babies are born premature. Sadly, prematurity is the leading cause of death in children under five.

World prematurity day is a global movement to raise awareness about premature birth and the hurdles babies and parents face every day to see their little one survive the day. Many survivors face a lifetime of disability, including learning disabilities and visual and hearing problems.

While World Prematurity Day is an opportunity to call attention to the heavy burden of deathand disability and the pain and suffering that preterm birth causes, it is also a chance to talk about Solutions.


The 10 countries with the greatest number of preterm births1:

  • India: 3 519 100 (1 in 7)
  • China: 1 172 300
  • Nigeria: 773 600
  • Pakistan: 748 100
  • Indonesia: 675 700
  • The United States of America: 517 400
  • Bangladesh: 424 100
  • The Philippines: 348 900
  • The Democratic Republic of the Congo: 341 400
  • Brazil: 279 300

In almost all countries with reliable data, preterm birth rates are increasing.Inequalities in survival rates around the world are stark. In low-income settings, half of the babies born at or below 32 weeks (2 months early) die due to a lack of feasible, cost-effective care, such as warmth, breastfeeding support, and basic care for infections and breathing difficulties. In high-income group, almost all of these babies survive.

Addressing preterm birth is now an urgent priority for reaching Millennium Development Goal. Participation from government agencies, NGO’s and private sector is required equally for research, policy making and execution of programs to reduce the toll of preterm birth in high-burden countries like India.

Why does preterm birth happen?

Common causes of preterm birth include multiple pregnancies, infections and chronic conditions such as diabetes and high blood pressure; however, often no cause is identified. There could also be a genetic influence. Better understanding of the causes and mechanisms will advance the development of solutions to prevent preterm birth.

Solution: begins with healthy mother and good antenatal care

  • Counselling on healthy diet, optimal nutrition, personal hygiene and substance abuse
  • Contact with health care professional
  • prematurity-blog-ACFM-delhi

    • Provision of antenatal steroids
    • Essential care during child birth and postnatal period to mother and child
    • Kangaroo mother care- exclusive breast feeding and skin to skin contact
    • Antibiotics to treat neonatal infections

Optimising Use of Antenatal Corticosteroids for Fetal Lung Maturity

Author: Rachna Gupta

It is a well-known fact that antenatal corticosteroids (ACS) reduce perinatal mortalityby reducing the incidence of respiratory distress syndrome (RDS) in premature babies (1).

Cochrane review 2017 reveals that a single course of ACS significantly reduces the incidence of neonatal death by 31%. Meta-analyses have revealed significantly reduced rates of RDS, intraventricular haemorrhage (IVH), necrotizing enterocolitis (NEC), infectious morbidity, need for respiratory support, and neonatal intensive care unit admission with ACS treatment. For the mother, corticosteroid use does not increase the risk of death or chorioamnionitis, although a non-significant risk of puerperal sepsis was found (1). Maximum benefit is after 24 hours to 7 days of completed course.

Two regimes are commonly used:

  • Betamethasone 12 mg I/M 24 hourly 2 doses
  • Dexamethasone 6 mg I/M 12 hourly 4 doses.

Betamethasone is proven to be better than dexamethasone in reducing the neonatal morbidity and mortality, and cause less incidence of chorioamnionitis(1,2). However, as the betamethasone salt available in India is different from that used in international trials (3), same conclusion cannot be drawn, and either dexamethasone or betamethasone may be used depending upon availability.

There is also concern over increased prevalence of undiagnosed maternal infections in India, hence, more trials are needed on safety of use of corticosteroids. One of the trials showed increase in neonatal mortality and maternal infection with use of ACS in low-income and middle-income countries (4).

Use of ACS in late preterm babies (34 – 37 weeks) and early term (37 – 39 weeks) has been a matter of controversy so far and more data are needed to either support or refute the use of ACS in these populations. There are definite short-term benefits (mainly in reducing transient tachypnea of newborn) with some complications like neonatal hypoglycemia and unknown long-term neurodevelopmental outcomes (6).

Studies in animal models and short term studies in human beings have shown that there is increased basal level of cortisol in babies exposed to even single dose of ACS and there is aggravated response to stress (5). Barker’s hypothesis for fetal programming of adult onset of cardiovascular diseases like hypertension, stroke and diabetes also implicates exposure to ACS as a risk factor though this remains to be proven in human studies.
Repeated use of ACS has been linked with autism, neuro-developmental delay, permanent changes in limbic system, midbrain, white matter paucity, cerebral palsy, reduced head circumference, fetal growth restriction, maternal glucose intolerance. All these effects have been more widely studied in animals, and in human beings it is still a speculation, and not proven.
More than 4 repeated doses have been linked with reduced head circumference and fetal growth restriction (7).

Recommendations on basis of current literature:

  • One needs to weigh the potential risks and benefits of ACS. Between 26 – 34 weeks, the potential benefits clearly outweigh the risks and one should not hesitate to give steroids where delivery is anticipated before 34 weeks.
  • The assessment for iatrogenic or spontaneous preterm delivery needs to be more stringent and senior and more than one obstetricians should be involved in decision taking to give steroids at optimal time, so that timing is such that single course is given when delivery is expected before 34 weeks, and the estimated time to deliver is between 48 hours – 7 days.
  • High risk of imminent delivery is strictly defined as (6)

    • Preterm labour with intact membranes and at least 3 cm dilation or 75% cervical effacement
    • Preterm labour with spontaneous rupture of membranes.
    • Expected preterm delivery for any other indication either through induction or caesarean section between 24 hours and 7 days, as determined by the obstetrical provider.
  • Single course of ACS may be repeated if gestational age is less than 34 weeks, more than one week has elapsed and delivery is strictly expected between 24 hours to 7 days.
  • Between 34 – 37 weeks, there are short-term benefits with unknown long-term side effects, and lung maturity tests (like QuantusFLM) may be useful to assess the need for ACS.
  • There is not enough data to support use of ACS after 37 weeks either for planned C-section or normal delivery (8,9).
  • Elective C-section should be postponed to 39 weeks as much as possible as risk for respiratory distress keeps reducing and is minimum after 39 weeks.


  • Roberts D, Brown J, Medley N, Dalziel SR, Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth, Cochrane Database Syst Rev. 2017 Mar 21;3:CD004454.
  • Baud O, Sola A; Corticosteroids in perinatal medicine: How to improve outcomes without affecting the developing brain? Semin Fetal Neonatal Med. 2007 Aug;12(4):273-9. Epub 2007 Mar 21. Review.
  • Use of Antenatal Corticosteroids in Preterm Labour; Operational Guidelines June 2014; Ministry of Health and Family Welfare, Government of India.
  • Fernando A et al; A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low- income and middle-income countries: the ACT cluster- randomised trial; Lancet. 2015 February 14; 385(9968): 629–639.
  • Waffarn F, Davis EP; Effects of antenatal corticosteroids on the hypothalamic-pituitary-adrenocortical axis of the fetus and newborn: experimental findings and clinical considerations; Am J Obstet Gynecol. 2012 Dec;207(6):446-54-
  • Beena D. Kamath-Rayne et al; Antenatal corticosteroids beyond 34 weeks gestation: What do we do now? Am J Obstet Gynecol. 2016 Oct;215(4):423-30.
  • Michael W. Church et al;Repeated courses of antenatal corticosteroids: Are there effects on the infant’s auditory brainstem responses?NeurotoxicolTeratol. 2010; 32(6): 605–610.
  • ACOG Committee Opinion number 713, August 2017
  • NICE guideline (NG 25) Preterm labour and birth (published Nov 2015)

Anomaly Practical Exam Candidate Schedule

9:00-11:00 Amutha Chandra
Suriya Pandian
Ashish Bhalodiya Karun Wadhwa
Ananya K Ashish Talekar Jeevan Jyothi Kari
Anitha A Geeta Bhusari Kamlesh Patel
Asha Ravindran Debabrata Maitra Kanchan Mukherjee
11:00-11:15 BREAK
11:20-13:30 Neelam Jain Preeti Allum Nithya Elango
Kshitij Dhuria Nikhil Sharma Preeti Kakkar
Manasi Dabholkar Narjit Kaur Shyam Nandan Gupta
Megha Kamlapurkar Minakshi Rakholia Pavithra Vengetesh
Rinshi Saira Rajan Rachna Thadeja
13:30-14:10 LUNCH
14:15-17:15 Seneesh Kr Vikraman Hemaben Aghera Surekha B
Amita Das Shrestha Aggarwal Sushma Meda
Sandip Chavan Pankaj Rote Vibha Bansal
Saurabh Chopra Smitha Mannepalli Vishwanth Tokala
Bela Bhatt Sumati Saxena Savita Chopra
Rajendra Jain Natasha Aggarwal Ramprakash G
  • The above candidates are eligible provided they bring the proof (hard copy) of their FMF UK approval of images and subject to payment of the fees as mentioned in the brochure.
  • Kindly note that candidates will have to arrange for their own lunch on the day of the practical exams (Options available at Apollo Food Court).